HOME >> BIOLOGY >> NEWS
Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue

MicroRNAs (miRNAs), tiny pieces of genetic material that can serve as stop signs for gene expression and protein synthesis, are thought to be important in the development of cancer. Now, researchers at Jefferson Medical College and the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia have developed a technique that allows them to find which miRNA genes are expressed and how in both cancerous and normal tissue.

Scientists, led by Carlo Croce, M.D., director of Jefferson's Kimmel Cancer Center and professor of microbiology and immunology at Jefferson Medical College, have developed a microarray chip onto which they were able to put all the known miRNA genes in both human and mouse. They found that each tissue they tested had its own characteristic pattern of miRNA gene expression.

The work might enable scientists to gain a better understanding of the roles of miRNAs in cancer and provide targets for future drug development. They reported their findings June 21, 2004 online in the Proceedings of the National Academy of Sciences.

Dr. Croce explains that miRNAs are thought to play important roles in regulating gene expression during development and cell differentiation. MiRNAs inhibit the function of their targets, typically messenger RNA, which is involved in gene expression. They either degrade the messenger RNA or block its translation. Cells in organisms from yeast to mammals make interfering RNA to shut off gene expression in development.

Dr. Croce and his colleagues had previously shown that deletions in miRNA genes were involved in B-cell chronic lymphocytic leukemia (CLL), the most common adult leukemia in the Western world. They also had reported that human miRNA genes are frequently located in "fragile" areas of the genome that are vulnerable to mutation. "We think the miRNA genes are in fact involved in many human cancers," he says.

"As a result, we have a number of markers that allow us to characterize spe
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
22-Jun-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... that Donald Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical ... simulation for drug and disease strategic data analytics, has joined the firm as ...
(Date:11/5/2019)... ... November 05, 2019 , ... Dr. Lauren Kopp ... dentistry to Seattle, WA, including porcelain veneers , smile makeovers, dental implants, ... University of Washington, Dr. Kopp is passionate about serving her Seattle community with ...
(Date:10/30/2019)... ... October 30, 2019 , ... The 2019 ... Center in which participants will learn about precision agriculture tools used to enhance ... technologies. , Participants will have the opportunity to visit Virginia Tech’s agricultural ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... , ... Modality Solutions, a biopharmaceutical cold chain ... workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, at the ... World Summit brings together pharmaceutical executives, cutting-edge technology providers, and media partners ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... ... provider, today announced integration of the Alertus Mass Notification System into its digital ... infrastructure to the Enplug platform, making it possible for users to leverage their ...
(Date:10/10/2019)... BETHESDA, Md. (PRWEB) , ... October 09, 2019 ... ... announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed ... place 27–30 October 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a ...
(Date:10/8/2019)... Fla. (PRWEB) , ... October 07, 2019 , ... ... development of low level laser therapy technology (“3LT®”), today announces that the U.S. ... market its EVRL low level laser for the temporary relief of chronic neck ...
Breaking Biology Technology:
Cached News: